Apalutamide (APA) and Overall Survival (OS) in Patients (PTS) with Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC): Updated Results from The Phase 3 Spartan Study
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI